ClinicalTrials.Veeva

Menu

Telemonitoring of CPAP Therapy in Apoplexy Patients With OSA

I

Institut für Pneumologie Hagen Ambrock eV

Status

Completed

Conditions

Apoplexy
OSA

Treatments

Other: Support
Device: CPAP therapy

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT01986452
StrOSA2013

Details and patient eligibility

About

Apoplexy patients with OSA are often not receiving a CPAP therapy due to generally poor acceptance and adherence. There is a great potential to significantly improve the treatment and care of these patients in a time economic way by telemonitoring the therapy in home environment.

This study is planned to prove that telephone consultancy and motivation in times of recorded decreasing CPAP therapy usage can improve adherence, neurological function and quality of life.

Full description

Eligible patients with confirmed OSA from neurological rehab department of Helios Clinic Hagen Ambrock are asked to join the study. They will be randomly assigned to one of two arms [CPAP with Telemonitoring (MTM) or without Telemonitoring (OTM)] for 6 months of home treatment after hospital discharge. The MTM arm will receive supporting phone calls when the monitored usage time decreases.

Enrollment

80 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • s/p ACM (Arteria Cerebri Media Insult)
  • Diagnosed OSA AHI >15/h
  • Barthel Index item 8 > 5 points (or home assistance)
  • Life expectancy >6 month
  • Capable of giving consent

Exclusion criteria

  • Already existing ventilatory support (CPAP, NIV etc)
  • Central AI >50% baseline
  • Central AI >5/h under CPAP therapy
  • Drug abuse
  • Pregnant or nursing women
  • Participation in another clinical trial last 4 weeks

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Unattended CPAP therapy
Active Comparator group
Description:
Therapy data will be examined by reading out the CPAP device after 6 months. Patients can obtain help on own request, corresponding to the standard CPAP prescription routine.
Treatment:
Device: CPAP therapy
Telemonitoring and support
Experimental group
Description:
CPAP device therapy data will be downloaded by the study site via GSM modules once a week. In case of poor therapy adherence (defined by a minimum average usage of 3h/night over the week) a contact call will be initiated to motivate patients or solve problems identified by telemonitoring. If active home intervention is required, the study site will inform the healthcare provider to visit the patient in a timely manner.
Treatment:
Device: CPAP therapy
Other: Support

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems